Yokoyama Shota, Hifumi Toru, Okazaki Tomoya, Noma Takahisa, Kawakita Kenya, Tamiya Takashi, Minamino Tetsuo, Kuroda Yasuhiro
1Department of Cardiorenal and Cerebrovascular Medicine, Kagawa University Hospital, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793 Japan.
2Department of Critical and Emergency Medicine, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560 Japan.
J Intensive Care. 2018 Dec 17;6:83. doi: 10.1186/s40560-018-0353-1. eCollection 2018.
In patients with aneurysmal subarachnoid hemorrhage (SAH), an association between hypocapnia and poor clinical outcomes has been reported. However, the optimal arterial carbon dioxide tension (PaCO) remains unknown. The present retrospective study aimed to examine the association of abnormal PaCO levels with neurological outcomes and investigate the optimal target PaCO level in patients with SAH.
We retrospectively selected consecutive adult patients hospitalized in the intensive care unit (ICU) for SAH between January 2009 and April 2017. Univariate and multivariate analyses were performed to identify the independent predictors of unfavorable neurological outcomes (i.e., modified Rankin scale score of 3-6 on hospital discharge).
Among 158 patients with SAH, 73 had unfavorable neurological outcomes. During the first 2 weeks in the ICU, the median number of PaCO measurements per patient was 43. The factors significantly associated with unfavorable neurological outcomes were age, Hunt and Kosnik grade, maximum lactate levels during the first 24 h, and maximum (odds ratio [OR], 1.12; 95% confidence interval [CI], 1.03-1.21; < 0.01) and minimum PaCO levels (OR, 0.81; 95% CI, 0.72-0.92; < 0.01). Receiver operating characteristic curve analysis revealed that the cutoff range of PaCO was 30.2-48.3 mmHg. Unfavorable neurological outcomes were noted in 78.8% of patients with PaCO levels outside this range and in 22.8% of patients with PaCO levels within this range.
Both the maximum and minimum PaCO levels during ICU management in patients with SAH were significantly associated with unfavorable neurological outcomes. Further prospective studies are required to validate our findings and explore their clinical implications. Our findings may provide a scientific rationale for these future prospective studies.
在动脉瘤性蛛网膜下腔出血(SAH)患者中,已报道低碳酸血症与不良临床结局之间存在关联。然而,最佳动脉二氧化碳分压(PaCO)仍不清楚。本回顾性研究旨在探讨异常PaCO水平与神经功能结局的关联,并调查SAH患者的最佳目标PaCO水平。
我们回顾性选择了2009年1月至2017年4月期间在重症监护病房(ICU)因SAH住院的成年连续患者。进行单因素和多因素分析以确定不良神经功能结局(即出院时改良Rankin量表评分为3 - 6分)的独立预测因素。
在158例SAH患者中,73例有不良神经功能结局。在ICU的前2周内,每位患者PaCO测量的中位数为43次。与不良神经功能结局显著相关的因素为年龄、Hunt和Kosnik分级、最初24小时内的最大乳酸水平,以及最高(比值比[OR],1.12;95%置信区间[CI],1.03 - 1.21;P < 0.01)和最低PaCO水平(OR,0.81;95% CI,0.72 - 0.92;P < 0.01)。受试者工作特征曲线分析显示,PaCO的截断范围为30.2 - 48.3 mmHg。PaCO水平超出此范围的患者中有78.8%出现不良神经功能结局,而PaCO水平在此范围内的患者中有22.8%出现不良神经功能结局。
SAH患者在ICU管理期间的最高和最低PaCO水平均与不良神经功能结局显著相关。需要进一步的前瞻性研究来验证我们的发现并探索其临床意义。我们的发现可能为这些未来的前瞻性研究提供科学依据。